Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David L DeMets

Showing results (1-10 of 98) with videos related to

Pageof 10
Sort By:
Science and Engineering Ethics|October 20, 2001
Statistics and ethics in medical researchDavid L DeMets
Clinical Trials (London, England)|December 15, 2011
Commentary on Anand et alDavid L DeMets
Statistics in Medicine|June 28, 2012
Current development in clinical trials: issues old and newDavid L DeMets
Statistics in Medicine|September 27, 2002
Clinical trials in the new millenniumDavid L DeMets
Clinical Trials (London, England)|December 16, 2006
Futility approaches to interim monitoring by data monitoring committeesDavid L Demets
Journal of Biopharmaceutical Statistics|January 31, 2006
Conditional and unconditional confidence intervals following a group sequential testXiaoyin Fan, David L DeMets
Journal of Biopharmaceutical Statistics|November 9, 2010
Review of draft FDA adaptive design guidanceThomas Cook, David L DeMets
The New England Journal of Medicine|September 23, 2016
Incentives for Clinical Trialists to Share DataBernard Lo, David L DeMets
JAMA|December 18, 2018
Challenges of Non-Intention-to-Treat AnalysesDavid L DeMets, Thomas Cook
Clinical Trials (London, England)|October 25, 2021
Data monitoring committee interim reports: We must get there soon!David L DeMets, Janet Wittes
Pageof 10

Showing results (1-10 of 98) with videos related to

Sort By:
Pageof 10
Science and Engineering Ethics|October 20, 2001
Statistics and ethics in medical researchDavid L DeMets
Clinical Trials (London, England)|December 15, 2011
Commentary on Anand et alDavid L DeMets
Statistics in Medicine|June 28, 2012
Current development in clinical trials: issues old and newDavid L DeMets
Statistics in Medicine|September 27, 2002
Clinical trials in the new millenniumDavid L DeMets
Clinical Trials (London, England)|December 16, 2006
Futility approaches to interim monitoring by data monitoring committeesDavid L Demets
Journal of Biopharmaceutical Statistics|January 31, 2006
Conditional and unconditional confidence intervals following a group sequential testXiaoyin Fan, David L DeMets
Journal of Biopharmaceutical Statistics|November 9, 2010
Review of draft FDA adaptive design guidanceThomas Cook, David L DeMets
The New England Journal of Medicine|September 23, 2016
Incentives for Clinical Trialists to Share DataBernard Lo, David L DeMets
JAMA|December 18, 2018
Challenges of Non-Intention-to-Treat AnalysesDavid L DeMets, Thomas Cook
Clinical Trials (London, England)|October 25, 2021
Data monitoring committee interim reports: We must get there soon!David L DeMets, Janet Wittes
Pageof 10